| ［1］ |
Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long⁃term narrowband UV⁃B phototherapy［J］. JAMA Dermatol, 2020,156（5）:529⁃537. doi: 10.1001/jamadermatol.2020.0218.
|
| ［2］ |
中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2018版）［J］. 中华皮肤科杂志, 2018,51（4）:247⁃250. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.001.
|
| ［3］ |
Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo［J］. J Am Acad Dermatol, 2017,76（5）:879⁃888. doi: 10.1016/j.jaad.2016.12.041.
|
| ［4］ |
中国医师协会皮肤科医师分会规范化诊疗工作委员会, 中国医学装备协会皮肤病与皮肤美容专业委员会皮肤外科装备学组和皮肤光治疗学组. 窄谱中波紫外线家庭光疗临床应用专家共识［J］. 中华皮肤科杂志, 2019,52（3）:156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2019.03.002.
|
| ［5］ |
许爱娥, 雷杰豪, 樊奇敏. 窄谱中波紫外线治疗白癜风治疗参数选择［J］. 中华皮肤科杂志, 2020,53（2）:89⁃92. doi: 10. 35541/cjd.20190523.
|
| ［6］ |
Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo［J］. Dermatology, 2016,232（2）:224⁃229. doi: 10.1159/000439563.
|
| ［7］ |
茅於彤, 朱晓芳, 王琴, 等.卤米松乳膏联合窄谱中波紫外线治疗白癜风疗效观察［J］. 中国美容医学, 2012,21（4）:615⁃616. doi: 10.15909/j.cnki.cn61⁃1347/r.2012.04.075.
|
| ［8］ |
Grimes PE, Hamzavi I, Lebwohl M, et al. The efficacy of afamelanotide and narrowband UV⁃B phototherapy for repigmentation of vitiligo［J］. JAMA Dermatol, 2013,149（1）:68⁃73. doi: 10.1001/2013.jamadermatol.386.
|
| ［9］ |
Lim HW, Grimes PE, Agbai O, et al. Afamelanotide and narrowband UV⁃B phototherapy for the treatment of vitiligo: a randomized multicenter trial［J］. JAMA Dermatol, 2015,151（1）:42⁃50. doi: 10.1001/jamadermatol.2014.1875.
|
| ［10］ |
Toh J, Chuah SY, Jhingan A, et al. Afamelanotide implants and narrow⁃band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians［J］. J Am Acad Dermatol, 2020,82（6）:1517⁃1519. doi: 10.1016/j.jaad.2020.01.035.
|
| ［11］ |
Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband⁃UVB （TL01） combined with tacrolimus ointment （0.1%） vs. placebo ointment, a randomized right/left double⁃blind comparative study［J］. J Eur Acad Dermatol Venereol, 2011,25（12）:1440⁃1443. doi: 10.1111/j.1468⁃3083.2011.04002.x.
|
| ［12］ |
Arora CJ, Rafiq M, Shumack S, et al. The efficacy and safety of tacrolimus as mono⁃ and adjunctive therapy for vitiligo: a systematic review of randomised clinical trials［J］. Australas J Dermatol, 2020,61（1）:e1⁃1e9. doi: 10.1111/ajd.13096.
|
| ［13］ |
Lee JH, Kwon HS, Jung HM, et al. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2019,155（8）:929⁃938. doi: 10.1001/jamadermatol.2019.0696.
|
| ［14］ |
Dang YP, Li Q, Shi F, et al. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta⁃analysis［J］. Dermatol Ther, 2016,29（2）:126⁃133. doi: 10.1111/dth.12295.
|
| ［15］ |
Relke N, Gooderham M. The use of Janus kinase inhibitors in vitiligo: a review of the literature［J］. J Cutan Med Surg, 2019,23（3）:298⁃306. doi: 10.1177/1203475419833609.
|
| ［16］ |
Karagaiah P, Valle Y, Sigova J, et al. Emerging drugs for the treatment of vitiligo［J］. Expert Opin Emerg Drugs, 2020,25（1）:7⁃24. doi: 10.1080/14728214.2020.1712358.
|
| ［17］ |
Rothstein B, Joshipura D, Saraiya A, et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib［J］. J Am Acad Dermatol, 2017,76（6）:1054⁃1060.e1. doi: 10.1016/j.jaad. 2017.02.049.
|
| ［18］ |
Kim SR, Heaton H, Liu LY, et al. Rapid repigmentation of vitiligo using tofacitinib plus low⁃dose, narrowband UV⁃B phototherapy［J］. JAMA Dermatol, 2018,154（3）:370⁃371. doi: 10.1001/jamadermatol.2017.5778.
|
| ［19］ |
Mobasher P, Guerra R, Li SJ, et al. Open⁃label pilot study of tofacitinib 2% for the treatment of refractory vitiligo［J］. Br J Dermatol, 2020,182（4）:1047⁃1049. doi: 10.1111/bjd.18606.
|
| ［20］ |
Phan K, Phan S, Shumack S, et al. Repigmentation in vitiligo using janus kinase （JAK） inhibitors with phototherapy: systematic review and Meta⁃analysis［J］. J Dermatolog Treat, 2020:1⁃5. doi: 10.1080/09546634.2020.1735615.
|
| ［21］ |
Olamiju B, Craiglow BG. Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child［J］. Pediatr Dermatol, 2020,37（4）:754⁃755. doi: 10.1111/pde.14159.
|
| ［22］ |
Hesseler MJ, Shyam N. Platelet⁃rich plasma and its utility in medical dermatology: a systematic review［J］. J Am Acad Dermatol, 2019,81（3）:834⁃846. doi: 10.1016/j.jaad.2019.04.037.
|
| ［23］ |
Ibrahim ZA, El⁃Ashmawy AA, El⁃Tatawy RA, et al. The effect of platelet⁃rich plasma on the outcome of short⁃term narrowband⁃ultraviolet B phototherapy in the treatment of vitiligo: a pilot study［J］. J Cosmet Dermatol, 2016,15（2）:108⁃116. doi: 10.1111/ jocd.12194.
|
| ［24］ |
Parambath N, Sharma VK, Parihar AS, et al. Use of platelet⁃rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double⁃blind randomized controlled trial［J］. Int J Dermatol, 2019,58（4）:472⁃476. doi: 10.1111/ijd.14286.
|
| ［25］ |
Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet⁃rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study［J］. J Cosmet Dermatol, 2020,19（4）:869⁃877. doi: 10.1111/jocd.13103.
|
| ［26］ |
Mercuri SR, Vollono L, Paolino G. The usefulness of platelet⁃rich plasma （PRP） for the treatment of vitiligo: state of the art and review［J］. Drug Des Devel Ther, 2020,14:1749⁃1755. doi: 10.2147/DDDT.S239912.
|
| ［27］ |
Kim WI, Kim S, Lee SH, et al. The efficacy of fractional carbon dioxide laser combined with narrow⁃band ultraviolet B phototherapy for non⁃segmental vitiligo: a systematic review and meta⁃analysis［J］. Lasers Med Sci, 2021,36（1）:165⁃173. doi: 10.1007/s10103⁃020⁃03069⁃0.
|
| ［28］ |
Mohammad TF, Hamzavi IH. Surgical therapies for vitiligo［J］. Dermatol Clin, 2017,35（2）:193⁃203. doi: 10.1016/j.det.2016.11. 009.
|
| ［29］ |
Ezz⁃Eldawla R, Abu El⁃Hamd M, Saied SM, et al. A comparative study between suction blistering graft, mini punch graft, and hair follicle transplant in treatment of patients with stable vitiligo［J］. J Dermatolog Treat, 2019,30（5）:492⁃497. doi: 10.1080/09546634. 2018.1528329.
|
